Patents Represented by Attorney, Agent or Law Firm Barbara Rae-Venter
-
Patent number: 6238669Abstract: Circular double-stranded replication intermediates were identified in low-molecular-weight DNA of cells of the avian leukemia virus-induced lymphoblastoid cell line 1104-X-5 infected with chicken anemia virus (CAV). To characterize the genome of CAV, we cloned linearized CAV DNA into the vector pIC20H. Transfection of the circularized cloned insert into chicken cell lines caused a cytopathogenic effect, which was arrested when a chicken serum with neutralizing antibodies directed against CAV was added. The 2,319-bp cloned CAV DNA contained all the genetic information needed for the complete replication cycle of CAV. The CAV genome probably contains only one promoter region and only one poly(A) addition signal. Southern blot analysis using oligomers derived from the CAV DNA sequence showed that infected cells contained double- and single-stranded CAV DNAs, whereas purified virus contained only the minus strand.Type: GrantFiled: August 13, 1997Date of Patent: May 29, 2001Assignee: Leadd, bvInventors: Mathews H. M. Noteborn, Gerden F. De Boer
-
Patent number: 6222097Abstract: Novel DNA constructs are provided which may be used as molecular probes or inserted into a plant host to provide for modification of transcription of a DNA sequence of interest in ovary tissue, particularly in very early fruit development. The DNA constructs comprise a transcriptional initiation regulatory region associated with gene expression in ovary tissue from immediately prior to anthesis through flower senescence.Type: GrantFiled: December 3, 1997Date of Patent: April 24, 2001Assignee: Calgene, LLCInventors: Kevin E. McBride, David M. Stalker
-
Patent number: 6217870Abstract: The coding information for three putative chicken anemia virus proteins (VP1, VP2, VP3) was inserted into a baculovirus vector and expressed in insect cells. The immunogenic properties of the chicken anemia virus (CAV) proteins produced separately or together in insect-cell cultures were analyzed by inoculating them into chickens. Only lysates of insect cells which have synthesized equivalent amounts of all three recombinant CAV proteins or cells which synthesized mainly VP1 plus VP2 induced neutralizing antibodies directed against CAV in inoculated chickens. Progeny of those chickens were protected against clinical disease after CAV challenge. Inoculation of a mixture of lysates of cells that were separately infected with VP1-, VP2- and VP3-recombinant baculovirus did not induce significant levels of neutralizing antibody directed against CAV and their progeny were not protected against CAV challenge.Type: GrantFiled: April 9, 1998Date of Patent: April 17, 2001Assignee: Leadd, bvInventors: Mathieu Hubertus Maria Noteborn, Guus Koch
-
Patent number: 6174700Abstract: A compound having a polysaccharide binding domain such as contained by a cellulose and essentially lacking in polysaccharidase activity is purified from other ingredients in a mixture using an affinity partition system. A mixture containing the compound is contacted with a system containing as a first phase an aqueous solution of oligosaccharide polymer such as cellulose and as a second phase a solution of a polymer such as a poly(ethylene glycol)-poly(propylene glycol) copolymer. The compound petitions into the first phase and binds to the oligosaccharide polymer, preferably with a Ka of 103 to 107, to form a complex. The complex is collected, and the compound is dissociated from the oligosaccharide polymer. The compound may be formed of a non-peptide chemical moiety or a peptide moiety linked to a polypeptide having the polysaccharide binding domain.Type: GrantFiled: July 24, 1995Date of Patent: January 16, 2001Assignee: University of British ColumbiaInventors: Charles A. Haynes, Peter Tomme, Douglas G. Kilburn
-
Patent number: 6162461Abstract: The coding information for three putative chicken anemia virus proteins (VP1, VP2, VP3) was inserted into a baculovirus vector and expressed in insect cells. The immunogenic properties of the chicken anemia virus (CAV) proteins produced separately or together in insect-cell cultures were analyzed by inoculating them into chickens. Only lysates of insect cells which have synthesized equivalent amounts of all three recombinant CAV proteins or cells which synthesized mainly VP1 plus VP2 induced neutralizing antibodies directed against CAV in inoculated chickens. Progeny of those chickens were protected against clinical disease after CAV challenge. Inoculation of a mixture of lysates of cells that were separately infected with VP1-, VP2- and VP3-recombinant baculovirus did not induce significant levels of neutralizing antibody directed against CAV and their progeny were not protected against CAV challenge.Type: GrantFiled: June 7, 1995Date of Patent: December 19, 2000Assignee: Leadd B.V.Inventors: Matheus Hubertus Maria Noteborn, Guus Koch
-
Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants
Patent number: 6140486Abstract: The present invention relates to compositions and methods for preparing poly-unsaturated long chain fatty acids in plants, plant parts and plant cells, such as leaves, roots, fruits and seeds. Nucleic acid sequences and constructs encoding PKS-like genes required for the poly-unsaturated long chain fatty acid production, including the genes responsible for eicosapentenoic acid production of Shewanella putrefaciens and novel genes associated with the production of docosahexenoic acid in Vibrio marinus are used to generate transgenic plants, plant parts and cells which contain and express one or more transgenes encoding one or more of the PKS-like genes associated with such long chain polyunsaturated fatty acid production. Expression of the PKS-like genes in the plant system permits the large scale production of poly-unsaturated long chain fatty acids such as eicosapentenoic acid and docosahexenoic acid for modification of the fatty acid profile of plants, plant parts and tissues.Type: GrantFiled: June 4, 1998Date of Patent: October 31, 2000Assignee: Calgene LLCInventors: Daniel Facciotti, James George Metz, Michael Lassner -
Patent number: 6124528Abstract: This invention relates to methods for the expression of sucrose phosphate synthase encoding sequences alone or in cooperation with sugar metabolizing enzyme sequences to modify the soluble solids in plant fruit tissue. Depending on whether sense or antisense sequences are used, the method permits an increased or decreased sweetness in plant fruit tissue, such as tomato fruit.Type: GrantFiled: April 6, 1998Date of Patent: September 26, 2000Assignee: Calgene LLCInventor: Christine Shewmaker
-
Patent number: 6124117Abstract: Novel polypeptide compositions and methods for their use are provided comprising fusion proteins in which the polysaccharide binding domain or functional portion thereof of a polysaccharidase is fused to a heterologous protein or is conjugated to a chemical moiety. The compositions can be synthesized or prepared by recombinant DNA technology. The compositions find use as removable labels.Type: GrantFiled: January 23, 1997Date of Patent: September 26, 2000Assignee: University of British ColumbiaInventors: Douglas G. Kilburn, Robert C. Miller, Richard A. J. Warren, Neil R. Gilkes
-
Patent number: 6096547Abstract: Constructs are provided for expression of physiologically active mammalian proteins in plant cells, either in culture or under cultivation. The constructs provide a promoter functional in a plant host, a structural gene coding for mammalian protein and a terminator functional in a plant host. The construct is introduced into a plant cell to become integrated into the plant genome for expression in the plant cells or plants. The plant cells may be harvested and the mammalian protein isolated in physiologically active form.Type: GrantFiled: July 31, 1998Date of Patent: August 1, 2000Assignee: Calgene, LLCInventors: Robert M. Goodman, Vic C. Knauf, Catherine M. Houck, Luca Comai
-
Patent number: 5981839Abstract: Regulatory regions from genes expressed during a particular developmental stage or in a specific tissue are identified employing cDNA screening. The resulting regulatory regions are manipulated for use with foreign sequences for introduction into plant cells to provide transformed plants having phenotypic property which can be modulated. The invention is exemplified with light, seed and fruit-specific promoters.Type: GrantFiled: March 7, 1997Date of Patent: November 9, 1999Assignee: Calgene, LLCInventors: Vic C. Knauf, Jean C. Kridl
-
Patent number: 5981502Abstract: Novel proteins of the Chicken Anemia Virus are described and compositions for preventing or treating infections with that virus (CAV), in particular vaccines less pathogenic than the CAV itself, but yet leading to neutralizing antibodies in the immunized animal. Besides, there are described compositions containing antibodies against parts of the CAV for the control of infections with CAV and anti-idiotype antibodies. The invention also provides antibodies and test kits for the detection of CAV. Recombinant DNA molecules derived from CAV and host cells transfected therewith and vaccines based on these host cells are made possible by this invention. The invention also comprises living virus vaccines in which apiece of DAN is brought into a virus infectious to the host. Besides, the Invention provides uses of proteins of CAV in the induction of apoptosis, in particular in tumor cells. It further provides the induction of cell death by means of gene therapy.Type: GrantFiled: June 7, 1995Date of Patent: November 9, 1999Assignee: Leadd B.V.Inventors: Matheus Hubertus Maria Noteborn, Guus Koch
-
Patent number: 5962289Abstract: Fusion proteins or conjugates are provided containing an amino acid sequence having a substrate binding region of a polysaccharidase such as cellulase that binds to a .beta.-1,4-glycan matrix such as cellulose. The substrate binding region is essentially without polysaccharidase activity. In the fusion protein, the substrate binding region is fused or chemically linked to a polypeptide such as an enzyme, a hormone, an immunoglobulin or a protein dye. By contacting the fusion protein with a .beta.-1,4-glycan matrix, the substrate binding region binds to the matrix to immobilize the polypeptide on the matrix. The polypeptide or fusion protein can be removed from the matrix with a protease acting on a protease recognition sequence or with a solution having a low ionic strength or high pH. In the conjugate, the substrate binding region is joined such as by covalent bonding to a non-protein chemical moiety such as a dye, chromophore, fluorescor, radionuclide or enzyme co-factor.Type: GrantFiled: January 24, 1997Date of Patent: October 5, 1999Assignee: The University of British ColumbiaInventors: Douglas G. Kilburn, Robert C. Miller, Richard A.J. Warren, Neil R. Gilkes
-
Patent number: 5958881Abstract: A method of inducing a temporary substantial paralysis of an area of interest in a patient undergoing a medical procedure is provided. The method involves administering a therapeutically effective amount of vasoactive intestinal peptide (VIP) admixed with a pharmaceutically acceptable carrier to a patient undergoing an endoscopy or other medical procedure.Type: GrantFiled: October 24, 1997Date of Patent: September 28, 1999Inventor: Louis Y. Korman
-
Patent number: 5958424Abstract: Recombinant genetic information (DNA or RNA), comprising a Chicken Anemia Virus (CAV)-specific nucleotide sequence and the use thereof for diagnostics, vaccination or protein production. Recombinant CAV protein and the use thereof for diagnostics, vaccination or production of CAV-specific antibodies. The use of CAV-specific antibodies thus obtained.Type: GrantFiled: August 13, 1997Date of Patent: September 28, 1999Assignee: Leadd BVInventors: Mathews H.M. Noteborn, Gerden F. De Boer
-
Patent number: 5952002Abstract: Novel proteins of the Chicken Anemia Virus are described and compositions for preventing or treating infections with that virus (CAV), in particular vaccines less pathogenic than the CAV itself, but yet leading to neutralizing antibodies in the immunized animal. Besides, there are described compositions containing antibodies against parts of the CAV for the control of infections with CAV and anti-idiotype antibodies. The invention also provides antibodies and test kits for the detection of CAV. Recombinant DNA molecules derived from CAV and host cells transfected therewith and vaccines based on these host cells are made possible by this invention. The invention also comprises living virus vaccines in which a piece of DNA is brought into a virus infectious to the host. Besides, the invention provides uses of proteins of CAV in the induction of apoptosis, in particular in tumor cells. It further provides the induction of cell death by means of gene therapy.Type: GrantFiled: August 14, 1997Date of Patent: September 14, 1999Assignee: Leadd, BVInventors: Matheus Hubertus Maria Noteborm, Guus Koch
-
Patent number: 5932476Abstract: Recombinant genetic information (DNA or RNA), comprising a Chicken Anemia Virus (CAV)-specific nucleotide sequence and the use thereof for diagnostics, vaccination or protein production are described. Recombinant CAV protein and the use thereof for diagnostics, vaccination or production of CAV-specific antibodies, and use of CAV-specific antibodies thus obtained, are also described. The cloned complete CAV DNA genome disclosed is representative of CAV in the field, worldwide. By means of PCR with primers derived from the cloned CAV genome, CAV-specific sequences corresponding with or complementary to the nucleotide sequence described can be detected. CAV harbors a specific promoter/enhancer element which regulates the CAV transcriptional activity. Based upon this, a sensitive CAV-specific PCR and a method for validating negative PCR results and for estimating the number of CAV DNA copies present in the analyzed sample have been developed.Type: GrantFiled: June 7, 1995Date of Patent: August 3, 1999Assignee: Leadd BVInventors: Mathews H. M. Noteborn, Gerden F. De Boer
-
Patent number: 5874308Abstract: Methods and compositions are provided for in vitro expansion of growth factor dependent cells. Expansion is effected through the use of growth factor conjugates that include a growth factor such as a steel factor and a polysaccharidase substrate binding region. The conjugates are immobilized by binding of the substrate binding region to a substrate of the polysaccharidase in a growth chamber for the cells.Type: GrantFiled: January 16, 1996Date of Patent: February 23, 1999Assignee: University of British ColumbiaInventors: Douglas G. Kilburn, Keith R. Humphries, James G. Doheny, Eric Jervis, Judie Alimonti
-
Patent number: 5843375Abstract: The present invention provides methods and compositions for inhibiting microbial growth through the use of aromatic aldehydes or alcohols for the purpose of disinfecting contaminated environments. The methods include the step of contacting the unsterile area with an amount of a aromatic aldehyde or alcohol sufficient to control growth of pathogenic microbes. The aldehyde or alcohol can be provided in a variety of formulations.Type: GrantFiled: June 7, 1995Date of Patent: December 1, 1998Assignee: Proguard, Inc.Inventors: Ralph W. Emerson, Bradford G. Crandall, Jr.
-
Patent number: 5839224Abstract: Methods and compositions based upon natural aromatic compounds are provided, which find use as pesticides. The pesticides are formulated in a variety of ways, including dusts, sprays, shampoos and soaps, and can be bound to a solid support or provided as bait or directly impregnated into organic matter infested by or susceptible to infestation by a target pest. Pests controlled include mosquitos, lice, ants, cockroaches, lice, and ticks.Type: GrantFiled: March 25, 1996Date of Patent: November 24, 1998Assignee: Proguard, Inc.Inventors: Ralph W. Emerson, Bradford G. Crandall, Jr.
-
Patent number: 5830735Abstract: Novel microbial host strains are provided which are transformed by a vector molecule comprising a DNA fragment encoding a lipolytic enzyme and a marker for selection, capable of producing active lipase. Said DNA fragment is preferably derived from a Pseudomonas species.Type: GrantFiled: December 1, 1992Date of Patent: November 3, 1998Assignee: Gist-Brocades NVInventors: Peter Michael Andreoli, Maria Mathilde Josphina Cox, Farrokh Farin, Suzanne Wohlfarth-Rippel